Johnson & Johnson unit Ethicon will now be on the hook for damages to 11,000 women implanted with defective pelvic mesh devices, after the High Court declined to hear its appeal of a ruling that found it failed to adequately warn about the devices’ risks.
The ACCC’s practice of successively refining witness statements without saving draft versions was “quite unfair”, says a judge overseeing the competition regulator’s criminal cartel case over a botched ANZ share placement.
Former Tennis Australia president Steven Healy has lost his bid for $4.3 million in indemnity costs against ASIC over its failed case over the rights to the Australian Open, with a judge finding the regulator’s case against him had “reasonable prospects of success” before trial.
Several labour hire firms and the Morrison government are facing a potential class action for allegedly forcing South Pacific Islanders to work on Australian farms for low wages and in poor conditions.
Hong Kong-based conglomerate CITIC has successfully struck out large portions of an amended defence by Mineralogy and its owner Clive Palmer in a dispute over the $5.8 billion Sino Iron project in Cape Preston, with a judge finding the changes would create “wholly disproportionate and unnecessary” steps just two months out from trial.
YouTube comedian Jordan Shanks has apologised to former NSW Deputy Premier John Barilaro for hurt caused by videos posted in 2020 and 2021 but won’t be paying any damages as part of a settlement of a high profile defamation case.
Western Power is not entitled to palm off the legal costs of defending a class action after an appeals court found it was negligent in causing the January 2014 Perth Hills bushfire which destroyed 57 homes, a court has said.
Lawyers for JPMorgan went to the ACCC’s office to review a draft statement of the investment bank’s then managing director Jeffrey Herbert-Smith, an immunity witness for the competition regulator in its troubled criminal cartel case over an ANZ share placement, a court has heard.
Three law firms and a consultancy are fighting a bid by defunct financial advisor Dover Financial to bring negligence claims against two lawyers over a so-called client protection policy found to be “an exercise in Orwellian doublespeak”.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
